Hidefumi Kasuga
HK
Hidefumi Kasuga
Ph.D.
Rate
About
Dr. Hidefumi Kasuga joined Taiho Ventures in 2022, bringing extensive experience in oncology drug discovery and development, with a specialization in developing compounds targeting the epidermal growth factor receptor (EGFR).
Frequently asked
Who is Hidefumi Kasuga?
Dr. Hidefumi Kasuga joined Taiho Ventures in 2022, bringing extensive experience in oncology drug discovery and development, with a specialization in developing compounds targeting the epidermal growth factor receptor (EGFR).
What is Hidefumi Kasuga's current role?
Hidefumi Kasuga is currently Ph.D..
Comments
No comments yet. Be the first to share your take.
Profile
About Hidefumi Kasuga
Hidefumi Kasuga is Ph.D.. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.